Evidence map›Paper›PMID 24554559›Full record

ArticleAngewandte Chemie (International ed. in English)2014

A visualizable chain-terminating inhibitor of glycosaminoglycan biosynthesis in developing zebrafish.

Brendan J Beahm, Karen W Dehnert, Nicolas L Derr, Joachim Kuhn, Johann K Eberhart, Dorothe Spillmann, Sharon L Amacher, Carolyn R Bertozzi

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Two 3'-Chemical science · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Modern Synthetic Avenues for the Preparation of Functional Fluorophores.Angewandte Chemie (International ed. in English) · 2017
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Brendan J BeahmDepartment of Chemistry and Molecular and Cell Biology, Howard Hughes Medical Institute, University of California, Berkeley, CA 94720 (USA).
Karen W Dehnert
Nicolas L Derr
Joachim Kuhn
Johann K Eberhart
Dorothe Spillmann
Sharon L Amacher
Carolyn R Bertozzi
The Ohio State University · USUniversity of California, Berkeley · USHeart and Diabetes Center North Rhine-Westphalia · DEHoward Hughes Medical Institute · USThe University of Texas at Austin · USUppsala University · SE

Funding

Zebrafish FacilityP01HD022486 · NICHD · UNIVERSITY OF OREGON · PI EISEN, JUDITH S · 1987 to 2017
$28.8M
Univ of Calif Berkeley Chemistry-Biology Interface ProgramT32GM066698 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI CHANG, CHRISTOPHER J., FRANCIS, MATTHEW B · 2004 to 2023
$7.5M
Mycobacterial Sulfation PathwaysR01AI051622 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI BERTOZZI, CAROLYN · 2002 to 2015
$6.0M
METABOLIC OLIGOSACCHARIDE ENGINEERINGR01GM058867 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI Carolyn Bertozzi · 1999 to 2026
$5.6M
Metabolic Engineering with Bioorthogonal Chemical ReportersR37GM058867 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI BERTOZZI, CAROLYN · 2009 to 2018
$4.7M
Genetic Analysis of Somitogenesis in ZebrafishR01GM061952 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI AMACHER, SHARON L · 2002 to 2011
$2.5M
Howard Hughes Medical InstituteNIAID NIH HHS R01 AI051622NICHD NIH HHS HD22486NICHD NIH HHS P01 HD022486NIGMS NIH HHS GM58867NIGMS NIH HHS GM61952NIGMS NIH HHS R01 GM058867NIGMS NIH HHS R01 GM061952NIGMS NIH HHS R37 GM058867NIGMS NIH HHS T32 GM066698
6 · The paper itself

Abstract

Heparan sulfate (HS) and chondroitin sulfate (CS) glycosaminoglycans (GAG) are proteoglycan-associated polysaccharides with essential functions in animals. They have been studied extensively by genetic manipulation of biosynthetic enzymes, but chemical tools for probing GAG function are limited. HS and CS possess a conserved xylose residue that links the polysaccharide chain to a protein backbone. Here we report that, in zebrafish embryos, the peptide-proximal xylose residue can be metabolically replaced with a chain-terminating 4-azido-4-deoxyxylose (4-XylAz) residue by administration of UDP-4-azido-4-deoxyxylose (UDP-4-XylAz). UDP-4-XylAz disrupted both HS and CS biosynthesis and caused developmental abnormalities reminiscent of GAG biosynthesis and laminin mutants. The azide substituent of protein-bound 4-XylAz allowed for rapid visualization of the organismal sites of chain termination in vivo through bioorthogonal reaction with fluorescent cyclooctyne probes. UDP-4-XylAz therefore complements genetic tools for studies of GAG function in zebrafish embryogenesis.

Indexed as

AnimalsChondroitin SulfatesClick ChemistryGlycosaminoglycansHeparan SulfateZebrafishchondroitin sulfate glycosaminoglycanChondroitin SulfatesGlycosaminoglycansHeparan Sulfatebiosynthesisclick chemistryglycosaminoglycansinhibitorszebrafish

Identifiers

PMID24554559
PMCPMC4029504
OpenAlexW2146385272

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.